What could cause poor absorption of oral progesterone in a patient?

Poor Absorption of Oral Progesterone: Causes and Solutions

The most common cause of poor oral progesterone absorption is taking the medication on an empty stomach, as food increases bioavailability approximately twofold. 1, 2

Key Factors Affecting Oral Progesterone Absorption

1. Food Intake (Most Critical)

Always advise patients to take oral progesterone with food. The FDA labeling explicitly states that "concomitant food ingestion increased the bioavailability of progesterone capsules relative to a fasting state" 1. Research confirms this increases the area under the curve (AUC) and maximum serum concentration (Cmax) by approximately 2-fold without affecting time to peak levels 2.

2. Formulation and Particle Size

• Micronized progesterone in oil achieves the highest absorption, with mean peak levels of 30.3 ng/ml at 2 hours 3
• Plain milled progesterone, micronized alone, or enteric-coated formulations all produce significantly lower peak levels (9.6-13.2 ng/ml) 3
• The physical characteristics of the progesterone preparation dramatically impact absorption 3

3. Inherent Low Bioavailability

Oral progesterone has intrinsically poor bioavailability:

• Only 8.6-10% bioavailability compared to intramuscular administration 2
• Greater than 90% undergoes first-pass hepatic metabolism 4
• This is why micronization was developed—to enhance absorption 1, 5

4. Extreme Interpatient Variability

There is considerable intersubject variability in progesterone absorption, with maximum serum concentrations ranging from 15.72 to 625.98 ng/ml after the same 300 mg dose 6. The extent of absorption appears to increase with age 6.

5. Drug Interactions

• Ketoconazole and other CYP3A4 inhibitors may actually increase progesterone bioavailability by inhibiting hepatic metabolism 1
• This is generally not a cause of poor absorption but rather enhanced absorption

6. Gastrointestinal Motility Issues

Progesterone itself slows gastrointestinal motility in a dose-dependent manner 7, which theoretically could affect its own absorption, though this is not well-studied.

7. Hepatic and Renal Impairment (Unstudied)

The FDA labeling explicitly states that the effect of hepatic or renal impairment on progesterone pharmacokinetics has not been studied 1. In patients with known liver disease, absorption patterns are unpredictable.

Clinical Approach When Suspecting Poor Absorption

If a patient appears to have inadequate clinical response to oral progesterone:

1. First, verify they are taking it with food (most common correctable cause)
2. Ensure they are using micronized progesterone (not plain milled)
3. Consider checking serum progesterone levels 2-3 hours post-dose (should reach 17-38 ng/ml with 100-200 mg doses) 1, 5
4. Switch to vaginal progesterone if oral route continues to be problematic—vaginal administration bypasses first-pass metabolism and achieves direct uterine uptake via local vagina-to-uterus transport 4
5. Consider intramuscular progesterone (17-OHPC) for critical indications like preterm birth prevention 8

Common Pitfall to Avoid

Do not assume oral progesterone "isn't working" without first confirming the patient takes it with food. This simple intervention doubles bioavailability and is the most easily correctable factor 2.

The absolute bioavailability of micronized progesterone remains unknown 1, and the wide interpatient variability means some patients may genuinely be poor absorbers despite optimal conditions 6. In such cases, switching to vaginal or intramuscular routes is appropriate rather than escalating oral doses indefinitely.